戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ace electrodes has been attempted to monitor uterine contraction.
2 further prostaglandin production and further uterine contraction.
3 tocia), suggesting that it is detrimental to uterine contractions.
4 1) and admission to the hospital for preterm uterine contractions (50% vs 9%; P = .002).
5 ding uterus, WIN2 dose-dependently increased uterine contraction amplitude.
6 ffects only after HYPX, reducing both MT and uterine contraction amplitude.
7 noid receptor agonist WIN 55,212-2 (WIN2) on uterine contractions (amplitude and rate) and micturitio
8                     Prostaglandins stimulate uterine contractions and are clinically used for cervica
9 lished roles of oxytocin (OT) is in inducing uterine contractions and labor.
10                                PGs stimulate uterine contractions and prepare the cervix for parturit
11 eight, frequency of prenatal visits, preterm uterine contractions, antepartum hemorrhages, placenta p
12            The mechanisms used to coordinate uterine contractions are not known.
13                 We assessed the frequency of uterine contractions as a predictor of the risk of spont
14                                         Each uterine contraction begins with a regional contraction,
15                               In addition to uterine contractions during labor and milk ejection duri
16                                              Uterine contractions during labor are known to be associ
17 ometrial activation is required to establish uterine contractions during labor.
18 den infant death syndrome and for regulating uterine contractions during labor.
19 s on the occurrence of precisely coordinated uterine contractions during labour.
20 targeting uterine cells in-vitro, inhibiting uterine contractions ex-vivo, while doubling uterine dru
21          The measurement of the frequency of uterine contractions has not been useful for reducing th
22                 Treatment intended to reduce uterine contractions include tocolytic agents, such as i
23                                              Uterine contraction is a central feature of PTB, so gain
24                      Preterm labor caused by uterine contractions is a major contributor to neonatal
25 preterm labour, but their ability to repress uterine contractions lasts </= 48 h and their use does n
26 ery increases with an increased frequency of uterine contractions, measurement of this frequency is n
27 ng of the heart rate well after the onset of uterine contractions (odds ratio, 3.9; 95 percent confid
28 potheses formed to explain the regulation of uterine contraction/relaxation.
29 ceptor agonists that act via cAMP can reduce uterine contractions to delay preterm labour, but their
30                                              Uterine contractions, triggered by prostaglandins, excit
31                                  The regular uterine contractions were recorded via a balloon cathete

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。